This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Mdxhealth, Sa. Active years: 2016-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2018
Title: E M D Schuuring: Innovator in Cervical Cancer Diagnostics
Introduction
E M D Schuuring is a notable inventor based in Groningen, Netherlands. He has made significant contributions to the field of cervical cancer diagnostics, holding 2 patents that focus on innovative methods for identifying and monitoring this critical health issue.
Latest Patents
His latest patents include groundbreaking work on the methylation of the EPB41L3 gene. This invention relates to methods and kits for identifying, diagnosing, prognosing, and monitoring cervical cancer. The methods involve determining the methylation status or the expression levels of specific genes, or a combination thereof. Another patent focuses on the detection and prognosis of cervical cancer, utilizing similar methodologies to enhance diagnostic accuracy.
Career Highlights
E M D Schuuring is associated with Mdxhealth, a company dedicated to advancing cancer diagnostics. His work at Mdxhealth has positioned him as a key player in the development of innovative solutions for cervical cancer detection.
Collaborations
Some of his notable coworkers include Wim Van Criekinge and Valerie Deregowski, who contribute to the collaborative efforts in research and development within the company.
Conclusion
E M D Schuuring's contributions to cervical cancer diagnostics through his patents and work at Mdxhealth highlight his commitment to improving healthcare outcomes. His innovative approaches are paving the way for more effective diagnostic tools in the fight against cervical cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile